Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nova Pacific Metals Corp. | YQ10 | Sep 30, 2024 | 0.19 | 0.00 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | Sep 30, 2024 | 5.65 | -0.88 |
Novabay Pharmaceuticals | B9P | Sep 30, 2024 | 2.80 | 0.00 |
Novacyt | NYZ | Sep 30, 2024 | 0.72 | -0.14 |
Novagold Resources Inc. | NGR | Sep 30, 2024 | 3.75 | -2.75 |
Novanta Inc. - | 1GSN | Sep 30, 2024 | 159.00 | 0.00 |
Novartis AG | NOTA | Sep 30, 2024 | 103.00 | +1.48 |
Novavax, Inc. | NVV1 | Sep 30, 2024 | 11.50 | -1.83 |
Novem Group S.A. | NVM | Sep 30, 2024 | 4.96 | -0.40 |
NOVINA S.A. E ZY 1,16 | T36 | Sep 30, 2024 | 0.24 | -0.84 |
Novo Nordisk A/S | NOVA | Sep 30, 2024 | 105.50 | -2.31 |
Novo Resources Corp | 1NO | Sep 30, 2024 | 0.05 | 0.00 |
Novo Resources Corp | 1NOR | 0.00 | 0.00 | |
NovoCure Limited - Ordinary Shares | 038 | Sep 30, 2024 | 13.82 | -1.18 |
NOVONIX ADR | GC30 | Sep 30, 2024 | 1.65 | +0.61 |
Novonix Limited | GC3 | Sep 30, 2024 | 0.42 | -5.54 |
NOVOTEK AB B SK-,25 | Z9D | Sep 30, 2024 | 5.06 | 0.00 |
Novozymes AS | NZM | Sep 30, 2024 | 63.00 | 0.00 |
Novozymes B | NZM2 | Sep 30, 2024 | 65.02 | +2.72 |
Novra Technologies Inc. | 7CV | Sep 30, 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | Sep 30, 2024 | 0.33 | +3.73 |
NOW Inc. | 11N | Sep 30, 2024 | 11.40 | +2.70 |
NP3 Fastigheter | N33 | Sep 30, 2024 | 23.35 | +1.30 |
NPC Inc | 59N | Sep 30, 2024 | 6.05 | -3.20 |
NRC Group | 8NR | Sep 30, 2024 | 0.28 | +4.56 |
NRG Energy Inc. | NRA | Sep 30, 2024 | 80.56 | +0.10 |
NRJ Group | NR8 | Sep 30, 2024 | 7.54 | -0.26 |
NRW Holdings Limited | 3NR | Sep 30, 2024 | 2.18 | +0.93 |
Ns United Kaiun Kaisha, Ltd. | 8WN | Sep 30, 2024 | 28.40 | +1.43 |
NSE SA | 7YM | Sep 30, 2024 | 28.50 | +1.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.